Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
The Endocrine System01:29

The Endocrine System

The endocrine system is an extensive network of glands – organs or tissues in the body that create chemicals that control many bodily functions, that secrete hormones, which are chemical messengers that play essential roles in regulating various bodily functions. These hormones are secreted into the bloodstream and travel throughout the body. They require specific receptors to convey signals to cells possessing these corresponding receptors. This complex signaling mechanism ensures that every...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Follicular Immune Checkpoint: PD-1/PD-L1 and Immune Tolerance in Oocyte Competence and IVF Failure.

International journal of molecular sciences·2026
Same author

Endometrial Microbiome Profiles in Women Evaluated for Infertility or Recurrent Miscarriage: A Single-Center Descriptive Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Nutritional Challenges and Strategies in Obese Critically Ill Patients with Gynecological Cancer: A Narrative Review.

Nutrients·2026
Same author

Reply to: operative heterogeneity in emergency cervical cerclage for membrane prolapse - beyond a uniform procedure.

Journal of perinatal medicine·2026
Same author

Isoprostanes and Isofurans in Infertility and Assisted Reproduction: What Do We Know So Far?

International journal of molecular sciences·2026
Same author

When Fertilization Is Not Enough: Maternal-Zygotic Transition as a Determinant of Embryo Competence in IVF.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Jul 16, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Endocrine Disruptors and Gynecological Malignancies.

Dimitris Baroutis1, Eleni Katsianou2, Konstantinos Koukoumpanis1

  • 11st Department of Obstetrics and Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece.

Diagnostics (Basel, Switzerland)
|July 15, 2026
PubMed
Summary

Endocrine-disrupting chemicals (EDCs) are linked to gynecological cancers like breast and endometrial cancer. Reducing EDC exposure, especially during development, is crucial for prevention and early detection strategies.

Keywords:
biomarkersbisphenol Abreast cancerendocrine disruptorsendometrial cancerenvironmental carcinogensgynecological malignanciesovarian cancerphthalatesrisk stratification

More Related Videos

Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

Related Experiment Videos

Last Updated: Jul 16, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

Methods to Test Endocrine Disruption in Drosophila melanogaster
09:43

Methods to Test Endocrine Disruption in Drosophila melanogaster

Published on: July 3, 2019

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

Area of Science:

  • Environmental Health
  • Gynecologic Oncology
  • Toxicology

Background:

  • Endocrine-disrupting chemicals (EDCs) disrupt hormonal balance, contributing to gynecological malignancies.
  • Evidence links EDC exposure to breast, endometrial, ovarian, and cervical cancers.

Purpose of the Study:

  • Synthesize current evidence on EDC exposure and gynecological cancers.
  • Examine molecular mechanisms, epidemiology, and clinical implications.
  • Assess diagnostic and prevention strategies.

Main Methods:

  • Comprehensive literature review across major databases (PubMed, Embase, Scopus, Cochrane).
  • Inclusion of systematic reviews, meta-analyses, cohort, and case-control studies.
  • Quality appraisal using Newcastle-Ottawa Scale, AMSTAR-2, and GRADE framework.

Main Results:

  • Major EDCs (bisphenols, phthalates, PCBs, pesticides, PFAS) show carcinogenic potential via hormonal and epigenetic pathways.
  • Strongest evidence links DDT/DDE to increased breast cancer risk (up to 3.7-fold).
  • Endometrial cancer associated with xenoestrogen mixtures; ovarian and cervical cancers show emerging links.

Conclusions:

  • EDCs contribute to gynecological cancers through convergent molecular pathways.
  • Causal inference is limited by observational data and exposure complexity.
  • Integrate EDC risk into models, use multi-omics biomarkers, and prioritize exposure reduction.